Adjuvant therapy for gastric cancer: How negative results can help patients

Journal of the National Cancer Institute

Volumn 99, Issue 8, 2007, Pages 580-582

  Ellenberg, Susan S ^a   Sun, Weijing ^a  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; CISPLATIN; DOXORUBICIN; EPIRUBICIN; ETOPOSIDE; FLUOROURACIL; FOLINIC ACID; GLUTATHIONE; FLEP PROTOCOL; UNCLASSIFIED DRUG;

ADJUVANT THERAPY; ADVANCED CANCER; CANCER ADJUVANT THERAPY; CANCER COMBINATION CHEMOTHERAPY; CANCER LOCALIZATION; CANCER MORTALITY; CANCER SURVIVAL; CLINICAL TRIAL; DISEASE FREE SURVIVAL; DOSE RESPONSE; DOSE TIME EFFECT RELATION; DRUG EFFICACY; DRUG TOLERABILITY; DRUG TREATMENT FAILURE; EDITORIAL; FOLLOW UP; HUMAN; LYMPHADENECTOMY; OVERALL SURVIVAL; PATIENT COMPLIANCE; PATIENT SELECTION; PRIORITY JOURNAL; SAMPLE SIZE; STOMACH CANCER; SURVIVAL RATE; TREATMENT OUTCOME; ADJUVANT CHEMOTHERAPY; NOTE; STOMACH TUMOR;

ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CHEMOTHERAPY, ADJUVANT; CISPLATIN; EPIRUBICIN; FLUOROURACIL; HUMANS; LEUCOVORIN; STOMACH NEOPLASMS; TREATMENT OUTCOME;

EID: 34247582223     PISSN: 00278874     EISSN: 14602105     Source Type: Journal    
DOI: 10.1093/jnci/djk162     Document Type: Editorial

References (14)

1. MacDonald JS, Smalley SP, Benedetti J, Hundahl SA, Estes NC, Stemmermann GN, et al. Chemoradiotherapy after surgery compared with surgery alone for adenocarcinoma of the stomach or gastroesophageal junction. N Engl J Med 2001;345:725-30.
2. Cunningham D, Allum WH, Stenning SP, Thompson JN, Van de Velde CJ, Nicolson M, et al. Perioperative chemotherapy versus surgery alone for resectable gastroesophageal cancer. N Engl J Med 2006;355:11-20.
3. Cascinu S, Labianca R, Barone C, Santoro A, Carnaghi C, Cassano A, et al. Adjuvant treatment of high-risk, radically resected gastric cancer patients with 5-fluorouracil, leucovorin, cisplatin, and epidoxorubicin in a randomized controlled trial. J Natl Cancer Inst 2007;99:601-7.
4. Mari E, Floriani I, Tinazzi A, Buda A, Belfiglio M, Valentini M, et al. Efficacy of adjuvant chemotherapy after curative resection for gastric cancer: A meta-analysis of published randomised trials. A study of the GISCAD (Gruppo Italiano per lo Studio dei Carcinomi dell'Apparato Digerente). Ann Oncol 2000;11:837-43.
5. Bajetta E, Buzzoni R, Mariani L, Beretta E, Bozzetti F, Bordogna G, et al. Adjuvant chemotherapy in gastric cancer: 5-year results of a randomised study by the Italian trials in medical oncology (ITMO) group. Ann Oncol 2002;13:299-307.
6. Gastrointestinal Tumor Study Group. Adjuvant therapy of colon cancer - results of a prospectively randomized trial. N Engl J Med 1984;31:737-43.
7. Coronary Drug Project Research Group. Clofibrate and niacin in coronary heart disease. JAMA 1975;231:360-81.
8. Multiple Risk Factor Intervention Trial Research Group. Multiple risk factor intervention trial. Risk factor changes and mortality results. JAMA 1982;248:1465-77.
9. Steering Committee of the Physicians' Health Study Research Group. Final report on the aspirin component of the ongoing Physicians' Health Study. N Engl J Med 1989;321:129-35.
10. Temple R, Ellenberg SS. Placebo-controlled trials and active-control trials in the evaluation of new treatments. Part 1: Ethical and scientific issues. Ann Intern Med 2000;133:455-63.
11. Gehan EA, Freireich EJ. Non-randomized controls in cancer clinical trials. N Engl J Med 1974;290:198-203.
12. Hellman S, Hellman DS. Of mice but not men. Problems of the randomized clinical trial. N Engl J Med 1991;325:1513-5.
13. Sasako M, Yamaguchi T, Kinoshita T, Fujii M, Nashimoto A, Furukawa H, et al. Randomized phase III trial comparing S-1 monotherapy versus surgery alone for Stage II/III gastric cancer patients (pts) after curative D2 gastrectomy (ACTS-GC study). 2007 GI Cancer Symposium 2007 (January 19-21; Orlando, FL); abstract 8.
14. Society for Clinical Trials Board of Directors. The Society for Clinical Trials opposes US legislation to permit marketing of unproven medical therapies for seriously ill patients. Clin Trials 2006;3:154-7.